VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 669 filers reported holding VANECK VECTORS ETF TR in Q1 2021. The put-call ratio across all filers is 1.04 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $84,967 | +15.2% | 2,740 | 0.0% | 0.01% | +16.7% |
| Q3 2023 | $73,733 | -53.3% | 2,740 | -47.7% | 0.01% | -53.8% |
| Q2 2023 | $157,776 | -6.9% | 5,240 | 0.0% | 0.01% | -13.3% |
| Q1 2023 | $169,514 | +377.0% | 5,240 | +322.6% | 0.02% | +400.0% |
| Q4 2022 | $35,538 | +18.5% | 1,240 | 0.0% | 0.00% | -25.0% |
| Q3 2022 | $30,000 | -11.8% | 1,240 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $34,000 | -41.4% | 1,240 | -18.4% | 0.00% | -33.3% |
| Q1 2022 | $58,000 | +132.0% | 1,520 | +94.9% | 0.01% | +100.0% |
| Q4 2021 | $25,000 | +8.7% | 780 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $23,000 | -14.8% | 780 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $27,000 | +8.0% | 780 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $25,000 | +400.0% | 780 | +290.0% | 0.00% | +200.0% |
| Q3 2017 | $5,000 | -50.0% | 200 | -60.0% | 0.00% | -50.0% |
| Q4 2016 | $10,000 | -95.6% | 500 | -94.1% | 0.00% | -95.1% |
| Q3 2016 | $225,000 | – | 8,500 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |